Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

http://www.wikidata.org/entity/Q46529900

about

Systemic VHL gene functions and the VHL disease Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment Control of the immune response by pro-angiogenic factors Circulating biomarkers in advanced renal cell carcinoma: clinical applications The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy Myeloid-derived suppressor cells as regulators of the immune system The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer Coordinated regulation of myeloid cells by tumours The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.Targeting immune suppressing myeloid-derived suppressor cells in oncology.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.The pre-metastatic niche: finding common ground.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis Myeloid derived suppressor cells in human diseases Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.Myeloid-derived suppressor cells: a novel therapeutic target.Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.Therapeutic implications of immunogenic cell death in human cancer.Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?Molecular pathways and targets in cancer-related inflammation.Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?

P2860

Q24605882-5BD036FB-AF82-429F-AABA-D31F9199EFA8 Q24606366-553C3244-F93D-4864-96F4-34A0AB1F57AA Q26775769-ED155CF8-D084-416A-813C-86D3EEC0CD29 Q26777205-06264D75-4D27-4B82-A3B7-BBA2AA55456E Q26799126-F9D2CA76-8E0C-40C1-AAE3-EAA4A8606F60 Q27004733-383BDF61-A99F-43EC-91EB-2FBBA808F41B Q27023770-1AEB6780-F4E0-49BE-BE98-EB6B0C835A66 Q28076760-E013EE85-6776-4A96-8D97-F31E522CC8B9 Q28080262-AB29B0A9-9481-4959-A348-7AF001534216 Q28082461-D0E492D7-6D17-4A70-92C0-3449A857D883 Q28131637-349F9AC3-E9E7-4AFB-A5FD-8396175DA4BA Q28391375-997570F6-333C-4111-8B25-AE8F103F327E Q28395157-286486EB-0997-4687-9423-12CB8949DB31 Q30317628-3E4938D3-2C5C-4B1F-BBD3-F9FE98D7BFF5 Q33786788-B290B4E1-E2CE-44C4-AD5C-1EF9E72E617E Q33835099-98E094D2-909F-4F14-B9DF-B9089706EA2B Q33978763-D4A3DF5A-14AD-491D-82E1-DEAA1E8F87CC Q34082067-9FDE3518-8D3C-4AB3-9CCC-40426652D828 Q34298754-3EEDF2B6-AA4E-47F4-9D54-D59B4E20880F Q34342357-FDBF8E12-D2A0-4663-B3F6-F10144343408 Q34566554-A511902B-15EE-4895-8A80-C7A831274278 Q35029951-CB56A229-6CB0-42D9-946A-711F5F696763 Q35546240-6DA89F27-C67E-4BAF-A915-E2EB9631420B Q35579455-9B1BDE6F-774D-4862-A140-970D346E77AF Q35721553-996CE72D-1D68-42CE-8A5E-9938661C2F2D Q36108579-2F6052DB-95B2-456E-B5CD-0503B7C26AD8 Q36338349-DAF4E1E4-CE0D-41AD-BEBD-B516AC54C48A Q36896764-E32FE4D4-F85D-48E6-80C3-93F40E2DCB16 Q36967364-599328B0-8B56-4781-A29B-CAAA00F26114 Q36971755-8D86F106-6622-4D7C-ACC2-505730AFEC30 Q37066106-9DDC880E-F191-47AA-A651-81DA81424165 Q37193568-2AAA72D0-E20C-47A4-8BAD-6A2A03461296 Q37376141-7A89E5F4-542C-403B-9AFB-AD250C3E273A Q37393000-71EFA42F-20D6-4879-9943-08391C7F2892 Q37409283-A2AE38AE-87D1-4289-9C44-299D12D0263D Q37434072-ED6BE4A6-46C4-4C96-9A89-C40BE9FC5253 Q37593466-A48AA4DE-479D-4EB4-9B04-F279360F8881 Q37613493-E9D33CE8-AEB0-454F-A523-2FF848B85562 Q37729131-A647E244-5847-4DFA-B6B6-2BB475DE9073 Q37765493-31AEB0E8-02B4-4B71-8A50-45B1C83F4F35

P2860

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

http://www.wikidata.org/entity/Q46529900

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@en

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@nl

type

label

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@en

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@nl

prefLabel

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@en

Oxidative stress regulates exp ...... ssion in renal cell carcinoma.

@nl

P1433

Q46529900-7CEB23E7-4B87-4DD1-ADC1-D1EBA4D6F915

P1476

Q46529900-D7E02B75-A5D9-483C-86FD-8C3E98FA961C

P2093

Q46529900-2D04FFFA-5094-41F8-B375-4F763839B3F3

Q46529900-331E8DEE-B13C-4604-8EA5-0EF86EDA08A8

Q46529900-6A76257E-9ED3-489A-A88A-E37BBD85E1B4

Q46529900-6CC6B9B2-2628-49A9-A8AA-C600A5D1732B

Q46529900-79B09FFC-FC65-40E2-BD62-99629971954C

Q46529900-7C8DA3A0-6EFF-471E-B9C4-36F70FC48C07

Q46529900-9B4002AD-E43E-4061-A5BD-DC4EFD3E3536

Q46529900-C1D61582-E8A1-47C9-9C2A-629937B3322F

Q46529900-D0E0C921-E851-4897-96A2-A6851BF0298A

Q46529900-EAC2035D-5A26-4471-A25B-B1542CB0AA42

P304

Q46529900-8C38FE01-7B6C-4576-B973-454BCADCF7A8

P31

Q46529900-9F98A17A-0DB4-42ED-BC8D-2C332080B9A6

P356

Q46529900-262709D3-1AB5-4821-821A-416809DDBCAA

P407

Q46529900-050E28DB-077D-4323-8A52-4628C43870D9

P433

Q46529900-2C73225A-74A8-476A-8178-4D7B70A2820C

P478

Q46529900-809311FE-E358-4742-8888-603BF8E6D134

P50

Q46529900-784ADAD0-8248-4BFF-B6B3-F40823AB0A8F

Q46529900-BA2BEAE1-DE5A-43E6-9F13-D84E76FFE14A

P577

Q46529900-CD287E4A-E75A-42DB-938D-E3EAB31D1220

P5875

Q46529900-D49A4FCD-408B-4774-8E6A-6066E1B302CD

P698

Q46529900-79F2A366-A364-45D4-8098-36FCCBBE0A28

P356

JIMMUNOL.181.1.346

P1433

Journal of Immunology

P1476

Oxidative stress regulates exp ...... ession in renal cell carcinoma

@en

P2093

Charles Rosser

http://www.w3.org/2001/XMLSchema#string

Dietmar Siemann

http://www.w3.org/2001/XMLSchema#string

Evgeniy Eruslanov

http://www.w3.org/2001/XMLSchema#string

Hubert Kübler

http://www.w3.org/2001/XMLSchema#string

Johannes Vieweg

http://www.w3.org/2001/XMLSchema#string

Philip Dahm

http://www.w3.org/2001/XMLSchema#string

Sergei Kaliberov

http://www.w3.org/2001/XMLSchema#string

Timothy Tseng

http://www.w3.org/2001/XMLSchema#string

Yoshihisa Sakai

http://www.w3.org/2001/XMLSchema#string

Zhen Su

http://www.w3.org/2001/XMLSchema#string

P304

346-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.181.1.346

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5288989

http://www.w3.org/2001/XMLSchema#string

P698

18566400

http://www.w3.org/2001/XMLSchema#string